Titan Pharmaceuticals
TTNP
#10544
Rank
โ‚น0.58 B
Marketcap
โ‚น438.26
Share price
-3.76%
Change (1 day)
30.60%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น417.34. In 2023 the company made an earnings per share (EPS) of -โ‚น704.45 an increase over its 2022 EPS that were of -โ‚น1,444.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น704.45-51.22%
2022-โ‚น1,444-15.61%
2021-โ‚น1,711-81.37%
2020-โ‚น9,183-77.52%
2019-โ‚น40,860-56.32%
2018-โ‚น93,547-59.51%
2017-โ‚น2,31,061-371.81%
2016โ‚น85,008-144.35%
2015-โ‚น1,91,657300%
2014-โ‚น47,914-121.54%
2013โ‚น2,22,459-151.38%
2012-โ‚น4,32,939-11.54%
2011-โ‚น4,89,409188.89%
2010-โ‚น1,69,411-10%
2009-โ‚น1,88,234
2007-โ‚น7,71,761-2.38%
2006-โ‚น7,90,584-39.13%
2005-โ‚น12,98,817-16.87%
2004-โ‚น15,62,345-22.43%
2003-โ‚น20,14,1084.9%
2002-โ‚น19,19,99061.9%
2001-โ‚น11,85,876-13.7%
2000-โ‚น13,74,11165.01%
1999-โ‚น8,32,757-35.87%
1998-โ‚น12,98,596-1824.71%
1997โ‚น75,294-102.4%
1996-โ‚น31,43,514

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,059-353.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น684.48-264.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น135.00-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น82.71-119.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.77-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น369.81-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA